Keithaiken (Talk | contribs) |
Keithaiken (Talk | contribs) |
||
Line 20: | Line 20: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
+ | <div class="oneText-Wrapper"> | ||
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683016" target="_blank" class="f12">Release Factor 1</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683016" target="_blank" class="f12">Release Factor 1</a></h3> | ||
<img src="https://static.igem.org/mediawiki/2018/9/97/T--Lethbridge--RF1.PNG" alt="RF1 construct"> | <img src="https://static.igem.org/mediawiki/2018/9/97/T--Lethbridge--RF1.PNG" alt="RF1 construct"> | ||
Line 28: | Line 30: | ||
<li>Brief description: Release factor 1 (RF1) works with release factor 2 and 3 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | <li>Brief description: Release factor 1 (RF1) works with release factor 2 and 3 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | ||
</ul> | </ul> | ||
− | + | </div> | |
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
+ | |||
+ | <div class="oneText-Wrapper"> | ||
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683017" target="_blank" class="f12>Release Factor 2</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683017" target="_blank" class="f12>Release Factor 2</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 36: | Line 44: | ||
<li>Brief Description: Release factor 2 (RF2) works with release factors 1 and 2 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | <li>Brief Description: Release factor 2 (RF2) works with release factors 1 and 2 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | ||
</ul> | </ul> | ||
− | + | </div> | |
− | + | </div> | |
+ | |||
+ | <div style="clear: both"></div> | ||
+ | |||
+ | <div class="oneText-Wrapper"> | ||
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683018" target="_blank" class="f12>Cysteine tRNA Synthetase</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683018" target="_blank" class="f12>Cysteine tRNA Synthetase</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 45: | Line 58: | ||
<li>Brief description: Cysteine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.</li> | <li>Brief description: Cysteine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.</li> | ||
</ul> | </ul> | ||
− | + | </div> | |
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
+ | |||
+ | <div class="oneText-Wrapper"> | ||
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683019" target="_blank" class="f12>Lysine tRNA Synthetase</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683019" target="_blank" class="f12>Lysine tRNA Synthetase</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 54: | Line 73: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683020" target="_blank" class="f12>Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha) </a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683020" target="_blank" class="f12>Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha) </a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 64: | Line 88: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683022" target="_blank" class="f12>Serine tRNA Synthetase (SerRS) </a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683022" target="_blank" class="f12>Serine tRNA Synthetase (SerRS) </a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 74: | Line 103: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683023" target="_blank" class="f12>Valine tRNA Synthetase (ValRS) </a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683023" target="_blank" class="f12>Valine tRNA Synthetase (ValRS) </a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 85: | Line 119: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683024" target="_blank" class="f12>Initiation Factor I (IF1)</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683024" target="_blank" class="f12>Initiation Factor I (IF1)</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 96: | Line 135: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683025" target="_blank" class="f12>Initiation Factor 3 (IF1)</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683025" target="_blank" class="f12>Initiation Factor 3 (IF1)</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 107: | Line 151: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683026" target="_blank" class="f12>Elongation Factor- Thermo Unstable (EF-Tu) </a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683026" target="_blank" class="f12>Elongation Factor- Thermo Unstable (EF-Tu) </a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 117: | Line 166: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683027" target="_blank" class="f12>Elongation Factor-Thermo Stable (EF-Ts)</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683027" target="_blank" class="f12>Elongation Factor-Thermo Stable (EF-Ts)</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 128: | Line 182: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683028" target="_blank" class="f12>MyoKinase (MK)</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683028" target="_blank" class="f12>MyoKinase (MK)</a></h3> | ||
<img src="https://static.igem.org/mediawiki/2018/c/ce/T--Lethbridge--MK.PNG" alt="MK construct"> | <img src="https://static.igem.org/mediawiki/2018/c/ce/T--Lethbridge--MK.PNG" alt="MK construct"> | ||
Line 141: | Line 200: | ||
</li> | </li> | ||
</ul> | </ul> | ||
− | + | </div> | |
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
+ | |||
+ | <div class="oneText-Wrapper"> | ||
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683029" target="_blank" class="f12>Nucleoside Diphosphate Kinase (NDK)</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683029" target="_blank" class="f12>Nucleoside Diphosphate Kinase (NDK)</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 148: | Line 213: | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
<li>Brief description: NDK is responsible for the exchange of a phosphates between different nucleoside diphosphates (NDP) and triphosphates (NTP). | <li>Brief description: NDK is responsible for the exchange of a phosphates between different nucleoside diphosphates (NDP) and triphosphates (NTP). | ||
− | |||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
− | + | <div class="oneText-Wrapper"> | |
+ | <div class="oneText-Text"> | ||
<h3><a href="http://parts.igem.org/Part:BBa_K2683030" target="_blank" class="f12>Peptidyl Prolyl Isomerase (PPiase)</a></h3> | <h3><a href="http://parts.igem.org/Part:BBa_K2683030" target="_blank" class="f12>Peptidyl Prolyl Isomerase (PPiase)</a></h3> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 162: | Line 231: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
</div> <!--this closes off the content div--> | </div> <!--this closes off the content div--> | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 01:16, 18 October 2018
The following constructs are improved by being cloned and confirmed to be into the pSB1C3 plasmid, thus making them able to express in E. coli and used for iGEM user applications. Our project focuses on encapsulation of cargo by protein nanocompartments. This technology can be used to encapsulate cell free systems. The Next Vivo project, designed by the Lethbridge iGEM team in 2017 is therefore an important and viable application for our toolkit. We hope in the future to try encapsulating this system as an alternative to liposome encapsulation as previously proposed for this project. The ability to target cell types could increase the cell free technology we are still developing.
Release Factor 1
- Original Part: BBa_K2443029
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief description: Release factor 1 (RF1) works with release factor 2 and 3 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.